Loading the public record
Loading the public record
Where They Stand is a nonpartisan guide to everyone running for Congress: their money, their own words and how incumbents voted. Find your ballot →
All recent votes114th CongressHouse
(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)
Stem Cell Therapeutic and Research Reauthorization Act of 2015
(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.
(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
Written by the nonpartisan Congressional Research Service, describing H.R. 2820 as public Law on Dec 18, 2015. It is not the text of the measure; a later amendment may have changed what it does.
House Dec 16, 2015
An Act to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
Passed · Two-thirds required
421 Yea 0 Nay 12 not voting
Crossed both parties No voting member broke with their own party.
DemocratsRepublicansFilled: YeaRing: NayGrey: not voting or present
433 members on this roll call, from the official House record. Party majorities need at least five voting members, so an independent never counts as breaking with a party.
Signing on is not a vote: a member can cosponsor H.R. 2820 and vote against it. 3 signed when it was filed.
Organizations that named H.R. 2820 in a lobbying disclosure. Only those that cited the bill by number appear, so this is a floor, not a full list.
28 disclosures name this measure. Retrieved from LDA.gov on 2026-10-05. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.